GNH USA

Europe — EMA

Oramorph (Morphine Sulfate Pentahydrate)

GNH USA supplies Oramorph (Morphine Sulfate Pentahydrate), an opioid analgesic for moderate to severe pain in adults. Request a quote for global supply.

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

1
Pack/s

What is Morphine Sulfate Pentahydrate?

Morphine Sulfate Pentahydrate, the active ingredient in Oramorph, is an opioid analgesic presented as an oral formulation for oral administration. It is indicated for the management of moderate to severe pain and is commonly prescribed for adult patients requiring strong analgesia after surgery, injury, or in chronic pain conditions.

GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for this controlled Schedule II opioid and ensuring compliance with local regulations.

What is Morphine Sulfate Pentahydrate used for?

Oramorph, an opioid analgesic, is used to manage pain that involves the central nervous system.

Postoperative pain: provides relief after surgical procedures. Cancer pain: alleviates severe pain associated with malignant disease. Acute severe injury pain: controls intense pain resulting from trauma. Chronic severe non‑cancer pain: offers long‑term analgesia for conditions such as severe osteoarthritis.

What are the side effects of Morphine Sulfate Pentahydrate?

Oramorph may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Sweating - Dry mouth - Itching

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Hallucinations - Anaphylaxis or severe allergic reactions - Adrenal insufficiency - Withdrawal syndrome

What precautions apply to Morphine Sulfate Pentahydrate?

When prescribing Oramorph, clinicians should observe several safety measures.

Assess pain level: determine appropriate opioid therapy and baseline pain score. Monitor respiratory function: observe for signs of respiratory depression, especially after dose changes. Evaluate for constipation: implement prophylactic laxatives as needed. Avoid use in patients with severe respiratory disease: consider alternative analgesics. Check for drug dependence: assess history of substance abuse. Store at ambient temperature: keep in original container, protect from moisture and light.

What does Morphine Sulfate Pentahydrate interact with?

Oramorph interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): additive respiratory depression. - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - Anticholinergic agents: increased risk of urinary retention. - Other opioids: risk of overdose.

Moderate Interactions (Monitor Closely): - SSRIs: potential for serotonin syndrome. - Diuretics: may enhance hypotensive effect. - Anticholinergics: may worsen constipation. - Alcohol: enhances sedative effects.

Frequently asked questions

What is Oramorph used for?+
Oramorph contains morphine sulfate pentahydrate and is prescribed for the management of moderate to severe pain in adult patients, such as postoperative pain, cancer‑related pain, or acute injury‑related pain. It is an opioid analgesic that provides strong pain relief when other analgesics are insufficient.
How does morphine sulfate pentahydrate work?+
Morphine sulfate pentahydrate binds to μ‑opioid receptors in the central nervous system, activating G‑protein pathways that inhibit adenylate cyclase, reduce calcium entry, increase potassium efflux, and suppress neuronal firing. This decreases transmission of pain signals and enhances descending inhibitory pathways, resulting in analgesia.
What is the usual dose of Oramorph?+
The dosage of Oramorph is individualized by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, age, renal and hepatic function, and other clinical factors. The prescriber determines the appropriate starting dose, titration schedule, and maximum daily limit, and adjustments are made according to therapeutic response and tolerability.
Is Oramorph safe in pregnancy or breastfeeding?+
Safety of morphine sulfate during pregnancy and lactation has not been definitively established; it is classified as a pregnancy category unknown. Opioids can cross the placenta and may be excreted in breast milk, potentially causing respiratory depression in the newborn. Use only if the potential benefit justifies the potential risk and under medical supervision.
How do I order Oramorph from GNH USA?+
To request Oramorph, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required cold‑chain handling), and assistance with import documentation.
How does Oramorph compare with other opioids?+
Oramorph, containing morphine sulfate, is a prototypical μ‑opioid receptor agonist and is often considered the gold standard for severe pain. Compared with synthetic opioids such as fentanyl or oxycodone, morphine has a longer half‑life, a well‑characterized safety profile, and is available in multiple oral formulations, but may cause more constipation and histamine‑mediated reactions.
How should Oramorph be stored and handled?+
Oramorph should be stored at ambient temperature, below 25 °C, in its original container, protected from moisture, light, and excessive heat. Keep the product out of reach of children and unauthorized persons. Do not crush or split tablets unless specifically instructed, and dispose of any unused medication according to local regulations.
How is Oramorph administered?+
Oramorph is administered orally, typically as a tablet or solution, and should be taken exactly as prescribed. The dose may be given at regular intervals or as needed for breakthrough pain, depending on the clinician’s instructions. Swallow tablets whole with water unless an oral solution is provided, and avoid chewing unless directed.
What are the most serious risks associated with Oramorph?+
The most serious risks of Oramorph include respiratory depression, severe hypotension, profound sedation, and the potential for dependence or abuse. Patients with compromised respiratory function, the elderly, or those taking other CNS depressants are at higher risk. Prompt medical attention is required if breathing becomes shallow or consciousness is impaired.
Who should not use Oramorph?+
Oramorph is contraindicated in patients with known hypersensitivity to morphine or other opioids, those with significant respiratory depression, acute or severe asthma, and in individuals who have taken monoamine oxidase inhibitors within the past 14 days. Caution is also advised for patients with severe hepatic or renal impairment, and it should not be used in children unless specifically indicated.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Morphine Sulfate Pentahydrate
Route
Oral Use
Manufacturer
L. Molteni And C. Dei F.Lli Alitti Società Di Esercizio S.P.A.
Origin
EU

Related products